Randomized double blind trial of megestrol acetate versus placebo for the treatment of inoperable hepatocellular carcinoma.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Megestrol (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 20 Sep 2013 Biomarkers information updated
- 23 Aug 2011 Primary endpoint 'Overall-survival-duration' has not been met.
- 23 Aug 2011 Results published in the British Journal of Cancer.